Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemia

Bone Marrow Transplantation

Volumn 32, Issue 11, 2003, Pages 1065-1069

  Kumar, S ^a   Litzow, M R ^a   Rajkumar, S V ^a  

^a MAYO CLINIC   (United States)

Author keywords

Allogeneic transplantation; Angiogenesis; CML; Microvessel density

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; PREDNISONE;

ACUTE DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW; BONE MARROW BIOPSY; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; MORPHOLOGY; MYELOMA; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; VASODILATATION;

ADULT; BONE MARROW; BONE MARROW EXAMINATION; DILATATION, PATHOLOGIC; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0348013203     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704260     Document Type: Article

References (39)

1. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis [see comments]. N Engl J Med 1995; 333: 1757-1763.
2. Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 1996; 32A: 2534-2539.
3. Li VW, Folkerth RD, Watanabe H et al. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 1994; 344: 82-86.
4. Maeda K, Chung YS, Ogawa Y et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996; 77: 858-863.
5. Vermeulen PB, Verhoeven D, Fierens H et al. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer 1995; 71: 340-343.
6. Gasparini G, Barbareschi M, Boracchi P et al. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am 1995; 1: 131.
7. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309-313.
8. Kini AR, Kay NE, Peterson LC. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 2000; 14: 1414-1418.
9. Padro T, Ruiz S, Bieker R et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637-2644.
10. Schneider P, Jerome MV, Paysant J et al. The role of angiogenesis in leukemia proliferation. Am J Pathol 1999; 155: 1007-1008.
11. Perez-Atayde AR, Sallan SE, Tedrow U et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815-821.
12. Aguayo A, Kantarjian H, Manshouri T et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240-2245.
13. Di Raimondo F, Palumbo GA, Molica S, Giustolisi R. Angiogenesis in chronic myeloproliferative diseases. Acta Haematol 2001; 106: 177-183.
14. Korkolopoulou P, Viniou N, Kavantzas N et al. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study. Leukemia 2003; 17: 89-97.
15. Lundberg LG, Lerner R, Sundelin P et al. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000; 157: 15-19.
16. Rajkumar SV, Leong T, Roche PC et al. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 2000; 6: 3111-3116.
17. Rajkumar SV, Greipp PR. Prognostic factors in multiple myeloma. Hematol Oncol Clin N Am 1999; 13: 1295-1314, xi.
18. Vacca A, Ribatti D, Roncali L et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503-508.
19. Mesa RA, Hanson CA, Rajkumar SV et al. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood 2000; 96: 3374-3380.
20. Vermeulen PB, Gasparini G, Fox SB et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996; 32A: 2474-2484.
21. Bostwick DG, Wheeler TM, Blute M et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996; 48: 47-57.
22. Vacca A, Ribatti D, Roncali L, Dammacco F. Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymphoma 1995; 20: 27-38.
23. Rajkumar SV, Fonseca R, Witzig TE et al. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma. Leukemia 1999; 13: 469-472.
24. Fox SB, Leek RD, Weekes MP et al. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995; 177: 275-283.
25. Ebos JM, Tran J, Master Z et al. Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia. Mol Cancer Res 2002; 1: 89-95.
26. Kumar S, Fonseca R, Dispenzieri A et al. Bone marrow angiogenesis in multiple myeloma: effect of therapy. Br J Haematol 2002; 119: 665-671.
27. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
28. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-10934.
29. Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 1997; 22: 251-256.
30. Bussolino F, Albini A, Camussi G et al. Role of soluble mediators in angiogenesis. Eur J Cancer 1996; 32A: 2401-2412.
31. Ellis LM, Fidler IJ. Angiogenesis and metastasis. Eur J Cancer 1996; 32A: 2451-2460.
32. Rajkumar SV, Mesa RA, Fonseca R et al. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 2002; 8: 2210-2216.
33. Fiedler W, Graeven U, Ergun S et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997; 89: 1870-1875.
34. Verstovsek S, Kantarjian H, Manshouri T et al. Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia. Cancer 2002; 94: 1517-1521.
35. Gunsilius E, Duba HC, Petzer AL et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 2000; 355: 1688-1691.
36. Mayerhofer M, Valent P, Sperr WR et al. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood 2002; 100: 3767-3775.
37. Janowska-Wieczorek A, Majka M, Marquez-Curtis L et al. Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 2002; 16: 1160-1166.
38. Folkman J. Angiogenesis-dependent diseases. Semin Oncol 2001; 28: 536-542.
39. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002; 94: 883-893.